These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21517761)

  • 41. Idiopathic widespread calcium pyrophosphate dihydrate crystal deposition disease in a young patient.
    Hayashi M; Matsunaga T; Tanikawa H
    Skeletal Radiol; 2002 Apr; 31(4):246-50. PubMed ID: 11904695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of inorganic pyrophosphate in aortic valve calcification.
    Rathan S; Yoganathan AP; O'Neill CW
    J Heart Valve Dis; 2014 Jul; 23(4):387-94. PubMed ID: 25803964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification.
    Narisawa S; Harmey D; Yadav MC; O'Neill WC; Hoylaerts MF; Millán JL
    J Bone Miner Res; 2007 Nov; 22(11):1700-10. PubMed ID: 17638573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Articular chondrocalcinosis. Microanalysis of pyrophosphate (PPi) in synovial fluid and plasma.
    Altman RD; Muniz OE; Pita JC; Howell DS
    Arthritis Rheum; 1973; 16(2):171-8. PubMed ID: 4351956
    [No Abstract]   [Full Text] [Related]  

  • 45. Adenine-(methoxy)-ethoxy-P
    Nassir M; Mirza S; Arad U; Lee S; Rafehi M; Yaw Attah I; Renn C; Zimmermann H; Pelletier J; Sévigny J; Müller CE; Fischer B
    Org Biomol Chem; 2019 Nov; 17(46):9913-9923. PubMed ID: 31720670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Chondrocalcinosis].
    Fallet GH; Vischer TL; Micheli A
    Schweiz Med Wochenschr; 1982 Jun; 112(25):888-97. PubMed ID: 7112058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of bone-type tissue-nonspecific alkaline phosphatase and PHOSPO1 in vascular calcification.
    Bobryshev YV; Orekhov AN; Sobenin I; Chistiakov DA
    Curr Pharm Des; 2014; 20(37):5821-8. PubMed ID: 24533943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcification of articular cartilage in human osteoarthritis.
    Fuerst M; Bertrand J; Lammers L; Dreier R; Echtermeyer F; Nitschke Y; Rutsch F; Schäfer FK; Niggemeyer O; Steinhagen J; Lohmann CH; Pap T; Rüther W
    Arthritis Rheum; 2009 Sep; 60(9):2694-703. PubMed ID: 19714647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inorganic pyrophosphate generation from adenosine triphosphate by cell-free human synovial fluid.
    Park W; Masuda I; Cardenal-Escarcena A; Palmer DL; McCarty DJ
    J Rheumatol; 1996 Apr; 23(4):665-71. PubMed ID: 8730124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Severe calcium pyrophosphate dihydrate deposition disease of the metacarpophalangeal joints.
    Rigsbee CA; Sizemore TC; Lohr KM
    BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30269092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The crowned dens syndrome. Evaluation with CT imaging.
    Scutellari PN; Galeotti R; Leprotti S; Ridolfi M; Franciosi R; Antinolfi G
    Radiol Med; 2007 Mar; 112(2):195-207. PubMed ID: 17361376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Juxta-articular joint-capsule mineralization in CD73 deficient mice: similarities to patients with NT5E mutations.
    Li Q; Price TP; Sundberg JP; Uitto J
    Cell Cycle; 2014; 13(16):2609-15. PubMed ID: 25486201
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chondrocytes From Osteoarthritic and Chondrocalcinosis Cartilage Represent Different Phenotypes.
    Meyer F; Dittmann A; Kornak U; Herbster M; Pap T; Lohmann CH; Bertrand J
    Front Cell Dev Biol; 2021; 9():622287. PubMed ID: 33981699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluating CPPD crystal deposition, an important disease of aging.
    Bonafede RP
    Geriatrics; 1988 Nov; 43(11):59-64, 68. PubMed ID: 2846412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retinoic acid stimulates pyrophosphate elaboration by cartilage and chondrocytes.
    Rosenthal AK; Henry LA
    Calcif Tissue Int; 1996 Aug; 59(2):128-33. PubMed ID: 8687982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantification of human plasma inorganic pyrophosphate. I. Normal values in osteoarthritis and calcium pyrophosphate dihydrate crystal deposition disease.
    Ryan LM; Kozin F; McCarty DJ
    Arthritis Rheum; 1979 Aug; 22(8):886-91. PubMed ID: 223577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group.
    Cai K; Fuller A; Zhang Y; Hensey O; Grossberg D; Christensen R; Shea B; Singh JA; McCarthy GM; Rosenthal AK; Filippou G; Taylor WJ; Diaz-Torne C; Stamp LK; Edwards NL; Pascart T; Becce F; Nielsen SM; Tugwell P; Beaton D; Abhishek A; Tedeschi SK; Dalbeth N
    Semin Arthritis Rheum; 2021 Aug; 51(4):946-950. PubMed ID: 34140183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crystal deposition disease in the elderly.
    Doherty M; Dieppe P
    Clin Rheum Dis; 1986 Apr; 12(1):97-116. PubMed ID: 3013494
    [No Abstract]   [Full Text] [Related]  

  • 59. [Chondrocalcinosis: idiopathic or manifestation of rare metabolic diseases?].
    Knitza J; Kleyer A; Schett G; Manger B
    Orthopade; 2019 Nov; 48(11):949-956. PubMed ID: 31515589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcium pyrophosphate crystal deposition disease and other crystal deposition diseases.
    Fam AG
    Curr Opin Rheumatol; 1992 Aug; 4(4):574-82. PubMed ID: 1503884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.